Volume 29, issue 4, Juillet-Août 2025

Éditorial

Oncolytic viruses in action: A successful unique case to be considered with caution (p.249-52)
David Olagnier, Tommy Alain
Free Access

Revue

Reoviruses: from replication cycle to oncolytic activity (p.253-69)
Guy Lemay

Antitumor immuno-virotherapy with attenuated strains of measles virus (p.271-91)
Jean-François Fonteneau, Nicolas Boisgerault, Frédéric Tangy

Oncolytic viruses for the management of pancreatic cancer: ongoing trials and therapeutic perspectives (p.293-311)
Agathe Redouté, Nikolaos Kontopoulos, Stéphane Bertagnoli, Pierre Cordelier

Retour de conférence

The 16^th Annual International Oncolytic Virotherapy Conference (IOVC) in Rotterdam: For the dreamers and doers of oncolytic virotherapy (p.312-24)
David Olagnier, Tommy Alain

English e-section

Oncolytic viruses in action: A successful unique case to be considered with caution (p.26-9)
David Olagnier, Tommy Alain
Free Access

Reoviruses : from replication cycle to oncolytic activity (p.30-45)
Guy Lemay
Free Access

The 16^th Annual International Oncolytic Virotherapy Conference (IOVC) in Rotterdam: For the dreamers and doers of oncolytic virotherapy (p.46-57)
David Olagnier, Tommy Alain
Free Access